Replies to post #92406 on Sunshine Biopharma Inc (SBFM)

[croutonpanda]

Jesus you're right. They must be coming down to the wire of available funds? Why else would they be going after toxic loans to stay afloat while making these opulent purchases to grow? Ballsy and I hope it works out.

[PRED2020]

So the Great Dr. didn't invent this? Get's more interesting daily.
And Advanomics gave up a multi $BILLION dollar drug for $4.32 million +R&D of course. Why would they do that?



The company acquired U.S. patent 8,236,935 for Adva-27a in October for a total $4.32 million—12 consecutive annual payments of $360,000—from Advanomics, which at the time owned approximately 23% of Sunshine's issued and outstanding common stock. Sunshine had licensed the U.S. patent from Advanomics for an annual fee of $360,000, plus reimbursement of Advanomics’ R&D expenses, under an agreement that was ended once the U.S. patent changed hands.